US 6444668
Combination regimens using progesterone receptor modulators
expired A61KA61K31/535A61K31/56
Quick answer
US patent 6444668 (Combination regimens using progesterone receptor modulators) held by Ligand Pharmaceuticals Incorporated expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Sep 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/535, A61K31/56